administers grant
- 3D co-culture system to characterize and target leukemia stem cells
- A Phase I Trial of Tazemetostat Combined with Venetoclax in Patients with Relapsed/Refractory NHL
- A Phase Ib trial of tazemetostat plus mosuntezumab in untreated follicular lymphoma
- A Program for Metastatic Breast Cancer Research
- A bioengineered model of tumor vessel interactions in pancreatic cancer
- A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.
- AIDS Malignancy Consortium (AMC)
- ASH transfer
- ATHN 17: Monitoring of venous thromboembolisms among non-hospitalized COVID-19 survivors
- ATHNdataset Hereditary Antithrombin Deficiency (HAD) Pilot Project
- Addgene 699808
- Addgene 700134
- Addgene 702304
- Addgene 705286
- American-Italian Cancer Foundation (AICF) Post-Doctoral Research Fellowship
- Automated Rapid Dual-Extraction of DNA and RNA from Single Cells in Microplates
- BRIDGE (Blood cancer Research Initiative Developing Greater Engagement) with Community Patients
- BioPharma Alliance Agreement- Janssen Research & Development
- Biophysical roles of pre-metatstatic niche evolution on transport of circulating tumor cells
- Characteristics and Outcomes of Patients with Follicular Lymphoma with at Least Two Prior Lines of Systemic Therapy and Treated at Cancer Centers within the LEO Cohort
- Characterization of the genomic and transcriptional landscape and role of tumor immune environment in multiple myeloma with extramedullary disease
- Characterizing The Biological And Mechanistic Nature Of The Elusive Lymphoma Stem Cell
- Clonal Hematopoiesis as a determinant for bone marrow toxicities for targeted radiation therapies in prostate cancer.
- Cohesin complex regulatory proteins and chromosomal architecture in normal and malignant B-cells
- Core: Targeting Enhancer Dysfunction in Hematological Malignancy- Core B
- DEVELOPMENT OF NEW MODELS OF THYMIC EPITHELIAL TUMORS
- Defining the epigenetic landscape and therapeutic vulnerabilities of Richter''s syndrome in CRISPR-based mouse models
- Determinants Of The Racial/Ethnic Disparity In MGUS Risk: An Epidemiologic Study In 4 Cohorts
- Development of Selective Small Molecule AR-V7 Inhibitors for Prostate Cancer Treatment
- Development of a platform for high throughput drug screening on CTC-derived organoid in breast and colorectal cancer
- Directing Fate, Subtype Identity And Survival In Human Pluripotent-Derived Midbrain Dopamine Neurons
- Early intervention for the prevention of blood cancer development.
- Elucidating Metabolic Pathways Regulating Germinal Center B Cells And Derived Lymphomas
- Epigenetic basis and therapeutic interdiction of FL progression
- Exploiting tumor metabolism to optimize T cell therapy
- Exploring the roles of EZH2 mutation for the development of double hit lymphoma and acquisition of chemotherapy resistance
- Heating cold prostate tumors with PSMA-targeted alpha therapy and pembrolizumab
- Immunogenomic determinants of ethnic disparities in clinical outcomes for urothelial cancer patients
- Immunologic Eradication of Myeloproliferative Neoplasm Stem Cells
- Immunomodulatory Ligand B7-1 Targets p75 Neurotrophin Receptor in Neurodegeneration
- Investigating the non-cell autonomous immune effects of mutant p53 in pancreatic cancer
- Janssen Biopharma Agreement
- Lymph node-targeted multistage chemoimmunotherapy for lymphoma
- Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling in Human Lymphomas
- Measuring Patient-Reported Outcomes Related to Radiopharmaceuticals for Prostate Cancer
- Metabolic and Inflammatory Response to a Whole Food Plant-Based Diet in Overweight/Obese Men with Prostate Cancer Receiving Androgen Deprivation Therapy: A Phase II Randomized Study
- Molecular Mechanisms of eIF4E mediated transformation
- Molecular and Translational Oncology Research
- Mutational and Aging Risk Factors for Myelodysplastic Syndrome
- Nanostructure-Enhanced Infra-Red Absorption Spectroscopy (NEIRAS) assay to improve Prognosis and Personalized Therapy of Drug-resistant Prostate Cancers
- Novel Approach to Improving Prostate Cancer Screening Among African American Men
- Novel Strategies for Induction of Aging in Human iPSC-Derived Lineages Towards Improved Models of Late-Onset Diseases
- Optimization Of Urinary DNA Deep Sequencing Tests To Enhance Clinical Staging Of Bladder Cancer Patients
- Pre-malignant mutation landscape and risk factors for progression to hematologic cancers
- Precision epigenetic therapy for SETD2+/- B cell lymphomas
- Precision translation of therapeutic regimens for follicular lymphoma
- Preventing follicular lymphoma progression and transformation through precision therapy
- Preventing follicular lymphoma progression and transformation through precision therapy
- Restoring lymphoma immunosurveillance by combined EZH2 inhibition and immunotherapy.
- Role of BCL10 somatic mutations in lymphomagenesis and response to BCR-targeted therapies
- Role of Chromatin Remodeling Complex BAF in Immunity and Lymphoma
- Role of chromatin remodeling complex BAF in immunity and lymphoma
- Role of the stromal microenvironment in B-cell lymphoma progression and immune escape
- SETD2 and H1 Project
- SRA with BMS
- Synthetic lethal strategies to limit tumor evolution driven by APOBEC3 activity in urothelial cancer
- Targeted Small Molecule Inhibitors for Inv(16) Leukemia
- Targeted Therapies
- Targeting Enhancer Dysfunction in Hematological Malignancy- Project 5
- Targeting Epigenetic Circuits in B-Cell Lymphomas
- Targeting MPN and Progenitor Cells
- Targeting Unmet Needs For B-cell Lymphomas
- Targeting cytidine deaminase-induced chromosomal instability as a driver of metastasis in bladder cancer
- Targeting immune escape in Cluster 5 DLBCL
- The Lymphoma Epidemiology of Outcomes (LEO)
- The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
- The Role of SPEN as Tumor Suppressor in BN2 DLBCL
- The impact of changes in chromatin architecture on cancer phenotypes and tumor progression
- Therapeutic Targeting of AR Variant Prostate Cancer with a Novel Antibody Drug Conjugate
- Therapeutic Targeting of SIRT3 for Aggressive and Refractory Lymphomas
- Tracking MPN Fitness to speed development of disease modifying agents for MPNs
- Transferrin Receptor Identifies a Comprehensive pool of Circulating Tumor Cells with unique molecular features from metastatic Prostate Cancer Patients
- Tumor-metabolism-driven therapies to overcome TNBC immune resistance
- Understanding and targeting metabolic rewiring in therapy-resistant B cell lymphomas
- Understanding the role of SPEN in DLBCL
- Utilizing EZH2 Inhibition to Improve Immune Therapies in Follicular Lymphoma
- Vitamin D and Follicular Lymphoma
- Zanubrutinib and Venetoclax as Initial Therapy for CLL with Obinutuzumab Consolidation in Patients with Minimal Residual Disease Positivity.